Effectiveness of cinacalcet treatment for secondary hyperparathyroidism on hospitalization: Results from the MBD-5D study.

by Shinji Asada, Kazuki Yoshida, Shingo Fukuma, Takanobu Nomura, Michihito Wada, Yoshihiro Onishi, Noriaki Kurita, Masafumi Fukagawa, Shunichi Fukuhara, Tadao Akizawa
Published 2019-01-01

Changes in 3-month mineral and bone disorder patterns were associated with all-cause mortality in prevalent hemodialysis patients with secondary hyperparathyroidism

by Chihiro Kato, Naohiko Fujii, Chisato Miyakoshi, Shinji Asada, Yoshihiro Onishi, Shingo Fukuma, Takanobu Nomura, Michihito Wada, Masafumi Fukagawa, Shunichi Fukuhara, Tadao Akizawa
Published 2020-10-01

Associations of employment status and educational levels with mortality and hospitalization in the dialysis outcomes and practice patterns study in Japan.

by Yasuo Imanishi, Shingo Fukuma, Angelo Karaboyas, Bruce M Robinson, Ronald L Pisoni, Takanobu Nomura, Takashi Akiba, Tadao Akizawa, Kiyoshi Kurokawa, Akira Saito, Shunichi Fukuhara, Masaaki Inaba
Published 2017-01-01

Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns S...

by Suguru Yamamoto, Angelo Karaboyas, Hirotaka Komaba, Masatomo Taniguchi, Takanobu Nomura, Brian A. Bieber, Patricia De Sequera, Anders Christensson, Ronald L. Pisoni, Bruce M. Robinson, Masafumi Fukagawa
Published 2018-10-01

Secondary hyperparathyroidism, weight loss, and longer term mortality in haemodialysis patients: results from the DOPPS

by Hirotaka Komaba, Junhui Zhao, Suguru Yamamoto, Takanobu Nomura, Douglas S. Fuller, Keith P. McCullough, Pieter Evenepoel, Anders Christensson, Xinju Zhao, Mona Alrukhaimi, Fadwa Al‐Ali, Eric W. Young, Bruce M. Robinson, Masafumi Fukagawa
Published 2021-08-01